CVRx (CVRX) Share-based Compensation Growth (3y) (2023 - 2026)
CVRx (CVRX) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 3.40% |
| 10 | CVRx | 76.50 Mn | 11.91 Mn | 13.72 Mn | 35.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.41% |
| Mar 31, 2026 | 19.59% |
| Dec 31, 2025 | 37.90% |
| Sep 30, 2025 | 45.95% |
| Jun 30, 2025 | 38.40% |
| Mar 31, 2025 | 45.74% |
| Dec 31, 2024 | 62.82% |
| Sep 30, 2024 | 78.15% |
| Jun 30, 2024 | 59.75% |
| Mar 31, 2024 | 467.37% |
| Dec 31, 2023 | 250.27% |
| Sep 30, 2023 | 266.97% |
| Jun 30, 2023 | 258.63% |